European Heart Journal

Article	Citations
Corrigendum to: Backup natural pacemaker found in the heart	8970
Residual leaks after transcatheter left atrial appendage closure: why and how to assess it?	4253
Intricacies of aortic risk assessment studies: not a simple matter	3775
Heart failure with preserved ejection fraction: underdiagnosed and undertreated in patients with tricuspid regurgitation	2333
Pulmonary haemodynamics and pulmonary congestion: where are we now?	2330
The Antwerp score: is this the ‘new hope on the horizon’?	1786
A newly designed glucagon-like peptide-1 receptor agonist reduces cardiovascular and renal events in high-risk type 2 diabetes	1679
Female representation on editorial boards of the National Societies of Cardiology Journals of the European Society of Cardiology	1352
A rare case of a dorsal mass caused by descending thoracic aortic dissection	1326
New Guidelines and a focus on ischaemic heart disease, atrial fibrillation, innovative treatments of channelopathies	1178
Corrigendum to: Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled	855
Meet the European Society of Cardiology Gold Medallists 2022	824
Strengthening cardiovascular trials across Australia and New Zealand—the Alliance for Cardiovascular Trials (ANZACT) Network	815
The COVID-19 pandemic and heart failure: lessons from GUIDE-HF	801
Unmeasured confounding is always unnerving: cannabis and cardiovascular risk	748
Additional value of 18fluorodeoxyglucose positron emission tomography/computed tomography combined with intracardiac echocardiography to detect lead vegetations	742
Obituary Joep Perk	719
Taking inspiration from birds to improve flow in prosthetic heart valves: an European Research Council granted project	672
The extended role of 24 h ambulatory blood pressure monitoring for reflex syncope	580
When two is not better than one: the amalgamation of atrial fibrillation and chronic obstructive pulmonary disease	566
Risk of knowing too much: the tricky case of estimated glomerular filtration rate and treatment decisions in heart failure	484
Stress echocardiography: the quest for risk stratification beyond myocardial ischaemia	460
Reconsidering safety and reducing barriers to MRI in patients with cardiac implantable electronic devices	408
A case of crowded heart: closing the door after the visitors	387
Isolated early peak cardiac troponin for clinical decision-making after elective cardiac surgery: useless at best	344

Doubly committed ventricular septal defect closure using an eccentric occluder via minimal incision in the anterior median sternum through the left parasternal third intercostal space	332
Elevated serum xylitol levels and cardiovascular risk: an active component or an innocent bystander?	306
Diffusion tensor imaging to assess myocardial microstructure after infarction by magnetic resonance	290
Increased right amygdala activity during the hyper-acute phase of takotsubo syndrome	270
Dissecting the effect of genetic variants on atherosclerosis: integrating bulk and single-cell transcriptomics	253
Weekly journal scan: a hard RAFTing to improve long-term survival in heart failure with severely reduced ejection fraction	243
Correction to: The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies	240
Early vascular disease of Olympian Paavo Nurmi despite a healthy lifestyle	238
Bulgarian Society of Cardiology: 50 years on	221
Weekly Journal Scan: no CLEAR evidence of cardiovascular benefits of colchicine after acute myocardial infarction	217
Crossing the chasm of donor organ recovery in heart transplantation	216
Does gut microbiota affect atrial rhythm? Causalities and speculations	203
Arterial conduits for coronary bypass grafting: the set-point concept	199
Correction to: Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score	195
The Year in Cardiovascular Medicine 2024: the top 10 papers in interventional cardiology	194
Mischief in the marrow: a root of cardiovascular evil	192
Promising perspectives on pregnancy in women with congenital heart disease	178
From a club of friends to an institution: past successes and future challenges for the European Society of Cardiology	176
Can we measurably improve the prediction of recurrent coronary artery disease events?	173
Suspected heart failure: a clinical pattern that calls for action	163
Hypernatremia and subclinical chronic kidney disease	155
Why Y? The Y chromosome may serve a cardiovascular purpose after all	155
One-shot thrombolysis for the management of acute ischaemic stroke	154
Do we need new thresholds for surgical repair in patients with ascending thoracic aortic aneurysm disease?	153
Correction to: 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary sy	152
Colchicine to prevent sympathetic denervation after acute myocardial infarction: the COLD-MI trial	152
Takotsubo syndrome is a coronary microvascular disease: experimental evidence	151
Acromegaly and cardiovascular outcomes: a cohort study	150
Weekly Journal Scan: The promise of small interfering RNA in reducing lipoprotein(a)	149
Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial	149
Cardiovascular events following coronavirus disease 2019 vaccination in adults: a nationwide Swedish study	148
Fate of the unoperated ascending thoracic aortic aneurysm: three-decade experience from the Aortic Institute at Yale University	146
Lipoprotein(a) levels in children with suspected familial hypercholesterolaemia: a cross-sectional study	143
Long-term night shift work is associated with the risk of atrial fibrillation and coronary heart disease	142
Toll-like receptor 2, hyaluronan, and neutrophils play a key role in plaque erosion: the OPTICO–ACS study	142
Nocturnal heat exposure and stroke risk	141
Leveraging global coronary flow assessments to inform revascularization benefit in chronic coronary disease: time to test total heart flow	140
Double counting in meta-analyses: a statistical complication in cardiovascular medicine trials	140
24 Hour blood pressure monitoring is a better predictor of mortality than clinic blood pressure in a large cohort of primary care patients: what is the impact on clinical practice?	138
The Australian–New Zealand SCAD observational cohort study: major adverse cardiovascular events are associated with ticagrelor combined with aspirin, FMD, and history of stroke	136
Setting the standard: Massimo Piepoli takes on lead editorial role	135
Expanding CAD assessment beyond coronary arteries: can body composition offer valuable insights?	135
Wild-type transthyretin cardiac amyloidosis: the need for a comprehensive geriatric assessment beyond age	131
ESC/HFA Quality of Care Centres: the ultimate frontier in unifying heart failure management	129
Association of transcatheter edge-to-edge repair with improved survival in older patients with severe, symptomatic degenerative mitral regurgitation	125
Brugada syndrome: can polygenic risk scores help the clinician?	125
Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction	123
Immune cells in cardiac homeostasis and disease: emerging insights from novel technologies	121
Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54	121
Single-cell technologies to decipher cardiovascular diseases	120

Beyond reproductive health: the cardiovascular risks of endometriosis	120
Proteomic cardiovascular risk assessment in chronic kidney disease	119
Stroke volume but not ejection fraction predicts prognosis in acute heart failure	118
Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation: an updated systematic review and meta-analysis	118
Impact of proNGF/NGF-NGFR-axis on the regulation of arterial remodelling	118
Progression, regression and redefining the treatment response – cardiac magnetic resonance with T1 and extracellular volume mapping in cardiac light-chain amyloidosis	117
Agreement between two independent raters in identifying exercise oscillatory ventilation in patients with heart failure	117
Cardioprotective effect of empagliflozin in acute myocardial infarction: the role of ketone bodies availability	116
Comparison of mechanical circulatory support with venoarterial extracorporeal membrane oxygenation or Impella for patients with cardiogenic shock: a propensity-matched analysis	116
A comparative analysis of conventional echocardiographic findings among different heart failure stages and phenotypes: insights from the national echocardiographic society registry	115
Amiodarone and the risk for pulmonary fibrosis. A Danish nationwide study	115
Effects of Sacubitril/Valsartan on all-cause hospitalizations in heart failure: participant-level pooled analysis of PARADIGM-HF and PARAGON-HF	114
Impact of left atrial strain assessed with feature-tracking computed tomography on long-term mortality after transcatheter aortic valve implantation	113
Spin-lock based magnetic field sensing: a non-invasive MRI method for spatially resolved imaging of cardiac conduction?	113
Beta-blockers after STEMI: prognostic impact and predictors of adherence, results from the real-world FAST-STEMI registry	112
Comparison of rapid test for high-sensitivity troponin I with laboratory high-sensitivity troponin T in patients with acute chest pain - a prospective monocentric study	112
Pnn deficiency alters expressions of calcium handling proteins and impairs nuclear envelope structure in cardiomyocytes	110
Long-term prognosis after ST-elevation myocardial infarction according to the Canadian Cardiovascular Society classification of tissue injury severity in acute myocardial infarction	109
Ten year survival after an acute heart failure episode	109
Outcomes of chronic total occlussion recanalization in patients with prior bypass-surgery: an updated systematic review and meta-analysis of real world registries	106
Utilization and safety of digoxin in patients with chronic heart failure and atrial fibrillation with rapid ventricular rate	106
Morphology-Voltage-P-wave duration (MVP) score in prediction of incident atrial fibrillation in an elderly epidemiologic cohort	106
Improving the prediction of major adverse cardiovascular events in patients with hypertrophic cardiomyopathy by adding plasma SVEP1 to conventional clinical model including NT-proBNP	105
Routine chest X-ray post cardiac implantable electronic device implantation: is it really required? Experience from a tertiary centre	105
The sooner the better? What is the optimal timing for coronary angiography in high-risk non-ST-elevation acute coronary syndrome	104
Remodeling of adult rat heart subjected to pressure overload from the neonatal period is dependent on the sex	104
Associations of maternal exposure to multiple plasma metals with the risk of fetal congenital heart defects: a prospective nested case-control study	104
Left atrial reservoir strain differentiates cardiac amyloidosis and hypertrophic cardiomyopathy	104
Reducing the burden of inconclusive smart-device single-lead ECG tracings via a novel atificial intelligence algorithm	103
Simulating atrial fibrillation patterns and screening strategies using virtual patient-level models	101
The role of cellular senescence in aortic dissection	100
Non-progressors to cardiac resynchronization therapy show long-term mortality benefit compared to progressors	100
The effect of Trimetazidine on the left ventricular global longitudinal strain assessed by cardiac magnetic resonance in stable angina patients with previous myocardial infarction and left ventricular	98
Further prognostic stratification in patients with oscillatory ventilation with exercise: is there more to it than just ups and downs?	97
Myocardial performance index improves prediction of major adverse cardiovascular events and heart failure in type 1 and type 2 diabetes without known heart disease: Thousand&1 and Thousand&2 s	97
Do health care physician need to risk their own lives? Time to change our own attitude towards recommended physical activity	96
Mortality and predictors of death in women and men with congestive heart failure of different types of cardiomyopathies	96
The novel P-Wave Area index predicts low voltage areas in patients undergoing pulmonary vein isolation for treatment of atrial fibrillation	95
Follow-up on new marker confirming the optimal status in the treatment of heart failure with reduced ejection fraction	93
Long-term follow-up of early leaflet thrombosis after transcatheter aortic valve replacement	93
Prognostic impact of the serial change of a systemic inflammation-nutrition index in patients with heart failure with preserved ejection fraction: insights from pursuit-hfpef registry	92
Eisenmenger syndrome: is it the same entity in adulthood and pediatric age?	92
Screening for subclinical atherosclerosis in patients clinically diagnosed with familial hypercholesterolemia and determination of imaging-guided patient management strategy	91
Effectiveness of empagliflozin in patients with heart failure and COPD: Results from EMPEROR-Preserved and EMPEROR-Reduced	90
Characteristics and long-term ablation outcomes of supraventricular arrhythmias in hypertrophic cardiomyopathy: a 10-year, single-center experience	90
Abnormal left-sided blood volume, wall shear stress & energy loss in patients with repaired Tetralogy of Fallot identified by 4D flow MRI	88
Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up	88
AD-9308 ameliorates the impacts of 4-HNE on the progress of pulmonary arterial hypertension in aldehyde dehydrogenase 2*1*2 knock-in mice	87
Use of emgliflozine in cardiotoxicity treatment. EMPACARD-treatment registry. Six-months follow-up	87
Vericiguat: a QTc interval study in patients with coronary artery disease	86
Elevated markers of liver function are associated with poorer outcomes in HFREF: an analysis of DAPA-HF	86
ARNI effects in HFrEF. Risk reduction beyond LVEF	84
Efficacy and safety of dapagliflozin in non-diabetic patients with primary anterior ST-elevation myocardial infarction initiated in early hospital period	84
Association between quantitative flow ratio and non-target-vessel-related events before planned staged percutaneous coronary intervention in patients with acute coronary syndrome	84
Survival in STEMI in resource limited settings - obstacles and potential solutions. Critical lesson learnt thorough a prospective observational study	83
Cardiometabolic outcomes in patients with overweight and obesity undergoing weight loss trials : a network meta-analysis	83
Real-world performance of a fully automatic antitachycardia pacing algorithm	83
Clinical profile and incidence of 36-month cardiovascular events in patients with MINOCA: a regional registry of 126 patients in a tertiary cardiology hospital	83
Long-term outcomes following DCB vs. DES for ISR treatment	82
Associated factors and clinical implications of dynamic changes in late gadolinium enhancement after acute myocarditis	81
Speckle tracking-derived left atrial stiffness predicts adverse events after successful electrical cardioversion	80
Plaque phenotyping using deep learning in optical coherence tomography imaging	80
Left atrial strain evaluation and prognostic value in constrictive pericarditis patients undergoing pericardiectomy	80
Less dementia in patients with newly diagnosed atrial fibrillation adhering with a clustering of healthy lifestyle behaviours: a nationwide population-based cohort study	79
The European Cardio Summit in Romania	79
Prediction of all-cause mortality in cardiovascular patients by using machine learning models	79
Identification of potential therapeutic targets for coronary artery disease based on protein array and Mendelian Randomization analysis	79
Evaluating off-target drug effects seen in RCTs using proteomics and mendelian randomisation	79
Coronary lesions suggestive of kawasaki disease in young patients presenting with acute myocardial infarction	78
Therapeutic components of an automated digital counselling intervention for chronic heart failure	78
Predictors of 1-year follow-up period MACE in patients with NSTEMI	78
Association between plasma desmosine, a marker of elastin degradation, and total atherosclerotic burden measured by whole body magnetic resonance angiography	78
Clinical characteristics and natural history of pre-adolescent non-syndromic hypertrophic cardiomyopathy	78
Correlation of Seattle Angina Questionnaire score and post-procedural outcomes in patients undergoing multi-vessel coronary intervention	78
A variant noncoding region regulates Prrx1 and predisposes to atrial arrhythmias	77
Ischemic stroke in patients with congenital heart disease and atrial fibrillation	76
Gender bias in ACS management	76
Use of sirolimus-coated balloon in de novo small vessel coronary lesions; Long-term follow-up from a single centre registry	75
The bimodal rise and fall acute coronary syndromes curves paralleling COVID-19 outbreaks	75
Real-world data from the use of ranolazine in patients with stable angina pectoris: the RANGER study	75

Effect of LPA gene on CAD risk among diabetic patients	74
NOAC in adult congenital heart disease patients: a single-center experience	74
Echocardiography in acute pulmonary embolism for the prediction of subsequent CTEPH	74
Prognostic value of cardiac magnetic resonance in elderly patients soon after ST-segment elevation myocardial infarction	74
Usefulness of CineECG method in identification of P-wave morphology variants in an elderly epidemiologic cohort	74
Prevalence of attention deficit/hyperactivity disorder (ADHD) in congenital heart diseases (CHD), a systematic review and meta-analysis	74
Concomitant real-time measurement and correlation of contact force to baseline local impedance and local impedance drops in RF ablation of left and right atrial procedures	73
Phenotyping coronary plaque by computed tomography in premature coronary artery disease	73
Phenotyping of heart failure with preserved ejection faction using health electronic records and echocardiography	73
The specificity of cardiac troponin elevations for myocardial infarction declines with age	73
Impaired right ventricular strain is associated with worse prognosis in patients with liver cirrhosis	73
The impact of worsening heart failure (WHF) status on subsequent outcomes among patients with HFrEF: History of WHF events is associated with worse subsequent outcomes regardless of extent of GDMT	72
Discovering an unknown risk. The unnoticed, potientially life-threatening risk to people with an inherited cardaic arrhythmia during the non-cardiac perioperative period.	72
Safety, tolerability, and basic pharmacokinetic parameters of AUX-001, a once-daily extended release nicorandil in healthy volunteers under fasting and fed conditions	72
Microvascular functional assessment using microvascular resistance reserve in patients undergoing elective fractional flow reserve-guided percutaneous coronary intervention	72
How can the detection of AF be improved? Insights from patient journeys and primary care clinicians	72
Cardiovascular safety of non-steroidal anti-inflammatory drug use for gout: A Danish nationwide case-crossover study	71
Prediction of outcome in malignant hypertension patients using machine learning: a report from the West Birmingham malignant hypertension registry	71
Safety and effectiveness of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS study	71
Artificial intelligence-assisted examination of cardiac health status through electrocardiogram	70
Safety of electrophysiological study in atrioventricular block risk stratification in new-onset persistent left bundle brunch block following transcathether aortic valve implantation	70
Much ado about nothing: the impact of coronary angiography on kidney function in individuals with chronic kidney disease	70
The role of sodium-glucose cotransporter 2 (SGLT2) inhibitors in epicardial adipose tissue modulation: a meta-analysis	69
A larger reduction of spatial mean QRS-T angle during cardiac resynchronisation therapy is associated with a lower risk of mortality and heart failure hospitalisation	69
Cardiovascular etiologies and risk factors of survival outcomes after resuscitation for out-of-hospital cardiac arrest: data from the KoCARC registry	69
Diagnostic accuracy of handheld single-lead electrocardiographic devices to detect atrial fibrillation: an examination using more than 30,000 rhythm traces in a randomised control trial	68
Quantifying cardiac tissue heterogeneity using high-density grid catheter: validation in porcine model	68
Is left atrial reservoir strain a superior modality to predict acute left ventricular failure in hypertensive patients	67
Calculation of intraprocedural hemodynamics with computational functional dynamic in mitral valve edge-to-edge repair	67
Blood pressure polygenic risk scores associate with resistant hypertension in individuals with type 1 diabetes	67
Permanent pacemaker implantation is associated with an increased risk of heart failure hospitalization in transcatheter aortic valve implantation patients with reduced systolic function	66
Survival penalty in patients undergoing transcatheter versus surgical aortic valve replacement: is it just a question of frailty? Insights from a large cohort with demographic matching	66
Practicing what you preach. Do cardiology trainees in the United Kingdom follow the lifestyle advice that they would give to patients?	65
What is there to EAARN with a CRT implantation? Predictive factors of mortality or clinical deterioration in patients receiving cardiac resynchronization therapy based on pre-implant factors	65
iRight4Me: individualisation of P2Y12 inihibitors in the realworld practice - an interim report	65
Extraction of leadless and tranvenous pacemakers: occurrence, causes and complications from a national US database	65
Improving early mortality risk detection in light-chain cardiac amyloidosis patients with routine echocardiographic indicators and mayo staging	65
Does the quality index of adherence to the evidence-based guidelines predict mortality in patients with myocardial infarction?	65
Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure	65
Implementing dynamic atrioventricular delay optimization for cardiac resynchronization therapy: an economic analysis in the EU5 countries	65
Factors for incorrect automated atrial fibrillation identification in large-scale screening	65
Duration of sinus rhythm after direct current cardioversion does not predict recurrence of atrial fibrillation after subsequent catheter ablation: a multicentre study	65
Dietary sodium intake and outcomes: a secondary analysis from SODIUM - HF	65
Atrial fibrillation organisation correlates with ventricular response regularity in patients with persistent atrial fibrillation	64
Quantitative assessment of myocardial fibrosis by digital image analysis: an adjunctive tool for pathologist ground truth	64
Preserved left ventricular ejection fraction with abnormal myocardial work in sepsis	64
Optimal CW-Doppler derived parameter for the diagnosis of iatrogenic mitral stenosis during transcatheter edge-to-edge repair for mitral regurgitation	63
Impact of aortic valve calcium score on conductive disturbances after transcatheter aortic valve implantation: a monocentre retrospective study	63
Prognostic role of data transmitted by implanted cardiac electric devices in patients with advanced heart failure referred for heart transplantation	62
Ultra-processed food consumption and risk of cardiovascular mortality in Australia: preliminary results from prospective observational study	62
Comparative study of the effects of left ventricular and biventricular pacing on indices of cardiac function and clinical status of heart failure patients: preliminary results of READAPT study	62
The role of seasonal influenza immunisation in cardiovascular care: a survey of cardiologists	62
Impact of the thin-walled sheath on the distal radial artery occlusion: a randomized trial	62
Incidentally induced atrial fibrillation during programmed electrical stimulation in patients with depressed left ventricular systolic function after an acute myocardial infarction: a CARISMA substudy	62
Dynamic changes of excessive trabeculation in dilated cardiomyopathy: a longitudinal cardiovascular magnetic resonance study	61
Multi-biomarker approach for predicting cardiac magnetic resonance parameters at 30 days after ST-segment elevation myocardial infarction	61
Acute deterioration in dyssynchrony and systolic function from Lot-CRT to LBBB pacing	61
Comparison of fully angiography-derived versus a hybrid of angiography and pressure-wire-derived approach to assess coronary microvascular resistance: the OxAMI-Hybrid study	61
The added value of advanced echocardiography in dilated cardiomyopathy: looking at the right heart	60
Prognosis of diastolic dysfunction in patients with preserved LVEF. Value of left atrial strain	59
Trimethylamine N-oxide as a Novel Biomarker for Left Ventricular Diastolic Dysfunction and Functional Remodeling in ST-Elevation Myocardial Infarction Patients	59
Cumulative accelerometer-based sedentary time from childhood through young adulthood with progressive left ventricular remodelling in British youth: a 13-year longitudinal study	59
Recent cardiac rehabilitation and its impact on cardiopulmonary exercise test variables in Brazilian cardiac transplant recipients	58
Endothelial dysfunction in acute coronary syndrome: a complex association with cardiovascular risk factors, sleep quality and cardiorespiratory capacity	58
Feasibility and efficacy of a novel 6 french sheathless guiding catheter equipped with peel-off type external dilator for PCI with distal radial approach - a Japanese multicenter study	58
Activation patterns of intracellular signaling pathways in cardiac hypertrophy induced by different exercise modes in rats	58
Comparative effects of ranolazine and trimetazidine on cardiac structure and exercise capacity in a healthy rat model: a new doping agent?	58
Safety and efficacy of perventricular device closure of ventricular septal defects in children	58
Cardiac troponin fragmentation in marathon runners. The MaraCat2 study	57
The gender difference in cause of death in Japanese atrial fibrillation patients: The Fushimi AF Registry	57
Multiparametric risk predictions for morbidity and mortality in patients with pulmonary arterial hypertension: insights from a nation-wide registry	57
Differences in left atrial stain, endothelial glycocalyx, arterial elasticity and myocardial efficiency between ESUS, lacunar, cardioembolic and atherosclerotic type of stroke	57
Acute infections and inflammatory biomarkers in patients with acute pulmonary embolism	57
Twenty-year trends in peripheral artery disease, lower extremity revascularization, and lower extremity amputation in newly diagnosed type 2 diabetes	56
Echocaridographic assessment of pulmonary hypertension: improving the probability	56
Cumulative accelerometer-based light physical activity from childhood through young adulthood progressively decreases left ventricular mass in British youth: a 13-year longitudinal study	56
Evaluating the safety and long-term efficacy of triple vasodilator therapy for pulmonary arterial hypertension associated with congenital heart disease	56
Physiological disease pattern as assessed by PPGI in vessels with FFR and iFR discordance	56
Real-time electrophysiological characterization of acute and chronic radiofrequency ablation lesions	55
T regulatory cells lose their protective phenotype in patients with coronary artery disease (CAD)	55
Clinical outcomes of deferred lesions by IVUS versus FFR-guided treatment decision: the FLAVOUR trial substudy	55
Effect of risk enhancers versus technical aspects of high thrombotic risk criteria on adverse clinical events after PCI: insights from 2020 ESC NSTE-ACS Guidelines	55
Continuous monitoring of heart failure biomarker using a sensitive graphene-based electrical sensor	55
Prevalence of diabetic nephropathy and subsequent cardiovascular outcomes: a nationwide study of 74,014 patients with type 2 diabetes	55
Novel cardiovascular magnetic resonance imaging heterogeneity biomarkers to diagnose and predict cardiovascular disease: a UK Biobank CMR strain study	55
Trends in infective endocarditis mortality in the United Kingdom and EU 15+ countries between 1990–2019: an analysis of the Global Burden of Diseases database	54
Percutaneous bioprosthetic aortic valve durability: results a single center after ten years of follow-up ago	54
Comparison of valve durability among different transcatheter and surgical aortic valve prostheses: a network meta-analysis	54
Association between the changes in walking speed during 6 months after discharge and subsequent prognosis in older patients with heart failure: report from a multicenter prospective cohort study	54
Left main coronary artery dimension and variation in Thai population	54
Comparison of mortality prediction scores in elderly patients with ICD for heart failure with reduced ejection fraction	53
His bundle pacing: safety, performance, and clinical outcomes in a single centre experience	53
Staging cardiac damage in aortic valve disease: one size fits all?	53
Association of Body mass index and clinical outcomes in patient with coronary artery disease undergoing percutaneous coronary intervention	53
Myocardial performance is impaired in cardiac amyloidosis: role of myocardial work-derived parameter in differential diagnosis with phenocopies and prognostic implications	53